A-234 (nerve agent)
A-234 is a highly potent nerve agent developed in Russia, believed to be a more powerful successor to the series of nerve agents known as "Novichok". The Novichok class of nerve agents were developed in the Soviet Union during the late 20th century as part of a program to create more effective and undetectable chemical weapons. A-234, specifically, gained international notoriety following its alleged use in the poisoning of former Russian spy Sergei Skripal and his daughter Yulia Skripal in Salisbury, England, in March 2018.
Chemical Properties and Mechanism of Action[edit | edit source]
A-234 is a part of the organophosphate family of chemicals, which act by inhibiting the enzyme acetylcholinesterase. This enzyme is crucial for the normal functioning of the nervous system, as it breaks down the neurotransmitter acetylcholine at synapses and neuromuscular junctions, allowing nerve cells to reset and communicate effectively. Inhibition of acetylcholinesterase leads to an accumulation of acetylcholine in the synaptic cleft, resulting in continuous stimulation of muscles, glands, and central nervous system structures. This overstimulation can cause a range of symptoms, from involuntary twitching to severe respiratory distress and death, due to asphyxiation from paralysis of the diaphragm.
Symptoms of Exposure[edit | edit source]
Exposure to A-234, like other nerve agents, can result in a variety of symptoms depending on the dose and route of exposure. Initial symptoms can include runny nose, tightness in the chest, and constriction of the pupils. As exposure increases, symptoms can escalate to include difficulty breathing, nausea, drooling, vomiting, and involuntary defecation and urination. Without immediate treatment, exposure to A-234 can lead to convulsions, paralysis, and ultimately, death due to respiratory failure.
Treatment[edit | edit source]
The primary treatment for A-234 exposure is the immediate administration of atropine, a drug that serves as an antidote by blocking the effects of acetylcholine at the receptor sites, and pralidoxime, which reactivates acetylcholinesterase if administered early enough. Supportive care, including oxygen and anticonvulsants, may also be necessary depending on the severity of the exposure.
International Response and Regulation[edit | edit source]
The use of A-234 and other Novichok agents is banned under the Chemical Weapons Convention (CWC), which prohibits the development, production, acquisition, stockpiling, or use of chemical weapons. The alleged use of A-234 in the Skripal poisoning led to international condemnation and heightened tensions between Russia and the West, with many countries expelling Russian diplomats in response. The incident underscored the challenges in regulating and controlling the proliferation of chemical weapons, particularly those that are newly developed and not explicitly listed in international treaties.
See Also[edit | edit source]
This chemical weapon related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD